CDC Launches Campaign to Fight Prescription Opioid Epidemic

Share this content:
CDC Launches Campaign to Fight Prescription Opioid Epidemic
CDC Launches Campaign to Fight Prescription Opioid Epidemic

TUESDAY, Sept. 26, 2017 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention is launching a communication campaign featuring accounts of people recovering from opioid use disorder, and those who have lost someone to opioid overdose, in an effort to fight the prescription overdose epidemic.

The CDC's campaign aims to increase awareness and knowledge of the risks associated with prescription opioids and stop inappropriate use. More than 183,000 people died in the United States from 1999 to 2015 from overdoses related to prescription opioids; more than 1,000 people are treated in emergency departments for misusing prescription opioids and more than 40 people die from prescription opioid overdoses every day.

The Rx Awareness campaign uses the tagline "it only takes a little to lose a lot," and employs testimonials to educate the public. The campaign is part of the CDC's Overdose Prevention in States efforts, which employ a five-point strategy to fighting the opioid epidemic: improving access to prevention, treatment, and recovery services; targeting availability of overdose-reversing drugs; strengthening the understanding of the crisis; providing support for research on pain and addiction; and advancing better pain management practices.

"This campaign is part of CDC's continued support for states on the frontlines of the opioid overdose epidemic," Brenda Fitzgerald, M.D., director of the CDC, said in a statement. "These heartbreaking stories of the devastation brought on by opioid abuse have the potential to open eyes -- and save lives."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »